Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane effects on ECG repolarization in diabetic versus non-diabetic surgical patients
ACTRN12610000259044Phase 4Completed
- Sponsor
- The Queen Elizabeth Hospital
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sevoflurane (2 arms), sponsored by The Queen Elizabeth Hospital. Primary endpoints: Difference in Tp-e interval between and within groups and Difference in Tp-e/QTc ratio between and within groups. Started Sep 2010; status: completed.
02
Drugs
sevoflurane
Beyond the preview
Go deeper on ACTRN12610000259044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000259044.